PL
ONC

Parkwood LLC’s BeOne Medicines Ltd ONC Stock Holding History

Parkwood LLC’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-9,055
Closed -$1.29M – 144
2024
Q2 		$1.29M Sell
9,055
-2,275
-20% -$351K 0.16% 86
2024
Q1 		$1.77M Buy
11,330
+4,866
+75% +$784K 0.16% 111
2023
Q4 		$1.17M Buy
6,464
+191
+3% +$34.6K 0.14% 81
2023
Q3 		$1.13M Buy
6,273
+278
+5% +$55K 0.12% 77
2023
Q2 		$1.07M Buy
5,995
+784
+15% +$181K 0.19% 74
2023
Q1 		$1.12M Buy
5,211
+563
+12% +$135K 0.15% 88
2022
Q4 		$1.02M Sell
4,648
-1,142
-20% -$209K 0.16% 86
2022
Q3 		$781K Sell
5,790
-943
-14% -$162K 0.12% 105
2022
Q2 		$1.09M Sell
6,733
-284
-4% -$44.4K 0.19% 99
2022
Q1 		$1.32M Buy
7,017
+296
+4% +$62.9K 0.22% 87
2021
Q4 		$1.82M Sell
6,721
-326
-5% -$110K 0.31% 71
2021
Q3 		$2.56M Buy
7,047
+1,495
+27% +$489K 0.31% 68
2021
Q2 		$1.91M Buy
5,552
+567
+11% +$188K 0.22% 78
2021
Q1 		$1.74M Sell
4,985
-2,898
-37% -$960K 0.31% 65
2020
Q4 		$2.04M Buy
+7,883
New +$2.17M 0.25% 74

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Parkwood LLC's ONC Position: Q3 2024 in Review

Parkwood LLC sold out of BeOne Medicines Ltd (ONC) in Q3 2024, closing a stake of 9,055 shares — an estimated $1.29M sold.

Parkwood LLC first reported a position in ONC in Q4 2020 and held it in 15 quarters. The position peaked at $2.56M in Q3 2021. 228 funds tracked by Wall St. Rank hold ONC as of Q3 2024.

  • Parkwood LLC reported no remaining BeOne Medicines Ltd position as of Q3 2024 after selling out during the quarter.
  • Parkwood LLC sold 9,055 BeOne Medicines Ltd shares in Q3 2024, an estimated $1.29M.
  • Parkwood LLC first reported a position in BeOne Medicines Ltd in Q4 2020 and held it in 15 quarters.
  • Parkwood LLC's BeOne Medicines Ltd position peaked at $2.56M in Q3 2021.
  • 228 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2024.

Based on Parkwood LLC's 13F filing for Q3 2024, filed 14 Nov 2024.